5-bromo-4-chloro-3-indolyl beta-galactoside has been researched along with Experimental Hepatoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Eguchi, K; Hamasaki, K; Ichikawa, T; Ishikawa, H; Matsumoto, K; Nakao, K; Nishimura, D | 1 |
Herberman, RB; Hirabayashi, H; Lin, WC; Vujanovic, NL; Whiteside, TL; Yasumura, S | 1 |
2 other study(ies) available for 5-bromo-4-chloro-3-indolyl beta-galactoside and Experimental Hepatoma
Article | Year |
---|---|
Bone marrow engraftment in a rodent model of chemical carcinogenesis but no role in the histogenesis of hepatocellular carcinoma.
Topics: Animals; beta-Galactosidase; Bone Marrow Transplantation; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Female; Galactosides; Graft Survival; Hepatocytes; Immunohistochemistry; Indoles; Liver Neoplasms, Experimental; Male; Mice; Mice, Transgenic; Stem Cells; Survival Rate | 2004 |
Immunotherapy of liver metastases of human gastric carcinoma with interleukin 2-activated natural killer cells.
Topics: Animals; Female; Galactosides; Humans; Immunotherapy, Adoptive; Indoles; Interleukin-2; Killer Cells, Lymphokine-Activated; Lac Operon; Liver Neoplasms, Experimental; Mice; Mice, Inbred BALB C; Stomach Neoplasms; Tumor Cells, Cultured | 1994 |